Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

Lynparza Maintenance Therapy Improves Survival in Relapsed, BRCA-Positive Ovarian Cancer

May 14th 2020, 1:27am

Article

Treatment with Lynparza in the maintenance setting extended overall survival by more than a year in women with platinum-sensitive relapsed ovarian cancer with BRCA1/2 mutations.

FDA Approves Combination of Lynparza and Avastin as Maintenance Treatment for Advanced Ovarian Cancer

May 8th 2020, 9:30pm

Article

Lynparza and Avastin are now approved for patients with advanced ovarian cancer that carries a specific mutation and has responded to previous treatment with platinum-based chemotherapy plus Avastin.

Ovarian Cancer

May 6th 2020, 6:08am

Article

Understanding ovarian cancer.

FDA Approves Zejula For Maintenance Treatment in Advanced Epithelial Ovarian Cancer

April 29th 2020, 11:20pm

Article

The Food and Drug Administration has approved the use of Zejula as a frontline maintenance treatment for adult patients with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer who responded to chemotherapy.

A Patient with Ovarian Cancer Weathers the COVID-19 Storm at Her Local Health Center

April 16th 2020, 10:14pm

Video

The COVID-19 pandemic has changed how people receive health care services. For Donna Wiegle, director of the Mill Pond Health Center in Maine, and cervical cancer survivor and patient with ovarian cancer, the pandemic hasn’t yet changed how her island’s health center provides residents with routine care.

Living with Peace of Mind As a Two-Time Cancer Survivor

April 14th 2020, 7:00pm

Article

A two-time survivor shares how taking action led her doctors to catch an aggressive second cancer.

Phase 3 Trial Fails to Improve Progression-Free Survival in Previously Untreated Epithelial Ovarian Cancer

April 13th 2020, 5:00pm

Article

After failing to meet its primary endpoint of progression-free survival, the JAVELIN Ovarian PARP 100 clinical trial was stopped.

Refine and Retry, Getting Ovarian Cancer Treatment Right for Patients

April 10th 2020, 5:26pm

Article

CURE®’s Editor-in-Chief weighs in on how the treatment and detection landscape needs to be refined to help patients with ovarian cancer.

Genetic Testing: Are Over-the-Counter Options Reliable?

April 9th 2020, 10:00pm

Article

An expert raises her concerns about direct-to-consumer testing and shares ways people can protect themselves.

Breastfeeding Lowers the Risk of Ovarian Cancer

April 8th 2020, 5:00pm

Article

Regardless of breastfeeding duration, women who did so after giving birth had a lower risk of developing ovarian cancer, including high-grade tumors.